AURORA, Colo. -- Pregnant patients with type 2 diabetes (T2D) treated with semaglutide (Ozempic) had mixed pregnancy outcomes, an observational study found. Among more than 4 million pregnancies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback